European Archives - Page 794 of 1218 - European Medical Journal

Broccoli’s Protective Effects on Kidney Health Linked to Genetics

A NEW STUDY has revealed that an individual’s genetics contributes to the benefits of a dietary compound on kidney health…

The Underlying Cause of Wilms’s Tumour Unravelled

WILMS’ TUMOUR, also knowns as nephroblastoma, is a rare kidney cancer that primarily affects children under the age of five….

Integrated Microbiota and Metabolite Profiles in Human and Mice Identified Functional Signatures in Crohn’s Disease with a Link to Sulphur Metabolism

Crohn’s disease (CD) is a chronic, remitting relapsing inflammatory disease of the gastrointestinal tract. Disease pathogenesis is suggested to be driven…

Review of the 27th United European Gastroenterology (UEG) Week Congress

One can walk in almost any direction through the bustling streets of Barcelona and be presented with constant reminders of the ingenuity and creativity…

‘Old but Gold’ – Insights About Anti-TNF-α Therapy in the Treatment of Inflammatory Bowel Disease

Prof Panaccione believed that biologic therapies are generally underutilised in patients with IBD; they are started too late and prescribed to too few…

EMJ Gastroenterology 8.1

In this edition of EMJ Gastroenterology, you will be treated to a thorough review of UEG Week 2019, encompassing synopses of the greatest abstract…

Making the Invisible Visible: The Hidden Cost of Paediatric Inflammatory Bowel Disease

Europe has the leading prevalence rates of inflammatory bowel diseases (IBD) in the world. It is estimated that 2.5–3.0 million people on the continent bear the condition,1 and the associated costs are on the rise…

What's New? A Year in Gastroenterology, Hepatology, and Endoscopy

Looking back on the last year, it is easy to be awestruck by the progression of clinical gastroenterology and hepatology research, one of the most notable…

Editor’s Pick: Refractory Gastroesophageal Reflux Disease: Pathophysiology, Diagnosis, and Management

Gastroesophageal reflux disease (GERD) is a common gastrointestinal (GI) disorder worldwide. Proton pump inhibitors (PPI) are the mainstay of treatment…

Burning Questions in Inflammatory Bowel Disease: Learnings from Emerging Drug Options and Clinical Cases

The treatment armamentarium is expanding for patients with UC and Crohn’s disease (CD). The treatments currently available include anti-inflammatory…